Multidirectional associations between the gut microbiota and Parkinson’s disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway
Open accessThe DOI matches its Crossref record; 286 of the 286 references it cites were found in a registry or an index.
Abstract
The human gastrointestinal tract is inhabited by a diverse range of microorganisms, collectively known as the gut microbiota, which form a vast and complex ecosystem. It has been reported that the microbiota-gut-brain axis plays a crucial role in regulating host neuroprotective function. Studies have shown that patients with Parkinson’s disease (PD) have dysbiosis of the gut microbiota, and experiments involving germ-free mice and fecal microbiota transplantation from PD patients have revealed the pathogenic role of the gut microbiota in PD. Interventions targeting the gut microbiota in PD, including the use of prebiotics, probiotics, and fecal microbiota transplantation, have also shown efficacy in treating PD. However, the causal relationship between the gut microbiota and Parkinson’s disease remains intricate. This study reviewed the association between the microbiota-gut-brain axis and PD from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway. We found that the interactions among gut microbiota and PD are very complex, which should be “multidirectional”, rather than conventionally regarded “bidirectional”. To realize application of the gut microbiota-related mechanisms in the clinical setting, we propose several problems which should be addressed in the future study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent analyses reveal that early constipation and gastrointestinal complaints are seen in 80% of PD patients [23, 24].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–286 of 286
Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Hou, Y., Li, X., Liu, C., Zhang, M., Zhang, X., Ge, S., & Zhao, L. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111376 · Cited by 101 · cited 1×
“Hou et al. found that administration of sodium butyrate achieved suppression of the neuroin fl ammation and alleviation of the neurological de fi cits in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated mouse PD models (Hou et al., 2021a).”
BackgroundQiao, C.-M., Sun, M., Jia, X.-B., Yang, L., Zhang, B.-P., Zhao, L., Shi, Y. W., Zhou, Z.-L., Zhu, Y., Cui, C., et al. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03074-3 · Cited by 99
Self-citationHoney bee genetics shape the strain-level structure of gut microbiota in social transmission
Wu, J., Lang, H., Mu, X., Zhang, Z., Su, Q., Hu, X., & Zheng, H. (2021) · Microbiome · doi:10.1186/s40168-021-01174-y · Cited by 99
Ahmed, S., Busetti, A., Fotiadou, P., Vincy Jose, N., Reid, S., Georgieva, M., Brown, S., Dunbar, H., Beurket-Ascencio, G., Delday, M. I., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00402 · Cited by 98
Williams, S., Chen, L., Savignac, H. M., Tzortzis, G., Anthony, D. C., & Burnet, P. W. (2016) · Synapse · doi:10.1002/syn.21880 · Cited by 91
The Microbiome and Risk for Atherosclerosis
Komaroff, A. L. (2018) · JAMA · doi:10.1001/jama.2018.5240 · Cited by 91
Alterations of gut microbiota and metabolome with Parkinson's disease
Yan, Z., Yang, F., Cao, J., Ding, W., Yan, S., Shi, W., Wen, S., & Yao, L. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105187 · Cited by 89
Suzuki, A., Ito, M., Hamaguchi, T., Mori, H., Takeda, Y., Baba, R., Watanabe, T., Kurokawa, K., Asakawa, S., Hirayama, M., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208313 · Cited by 88
Microbiota and Microglia Interactions in ASD
Davoli-Ferreira, M., Thomson, C. A., & McCoy, K. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676255 · Cited by 88
Heym, N., Heasman, B. C., Hunter, K., Blanco, S. R., Wang, G. Y., Siegert, R., Cleare, A., Gibson, G. R., Kumari, V., & Sumich, A. L. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05230-2 · Cited by 83
Rosa, A. I., Fonseca, I., Nunes, M. J., Moreira, S., Rodrigues, E., Carvalho, A. N., Rodrigues, C. M. P., Gama, M. J., & Castro-Caldas, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.004 · Cited by 82
Tong, Q., Zhang, L., Yuan, Y., Jiang, S., Zhang, R., Xu, Q., Ding, J., Li, D., Zhou, X., & Zhang, K. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.016 · Cited by 81
Matsumoto, M., Ooga, T., Kibe, R., Aiba, Y., Koga, Y., & Benno, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169207 · Cited by 80
The role of the gut–brain axis in alcohol use disorders
Gorky, J., & Schwaber, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.013 · Cited by 78
Human behavioral assessments in current research of Parkinson’s disease
Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Kobayashi, S. S., Hong, Z., Suzuki, K., Mori, N., Yang, Y., Hua, F., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.036 · Cited by 78
Self-citationGastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence
Pellegrini, C., Antonioli, L., Colucci, R., Ballabeni, V., Barocelli, E., Bernardini, N., Blandizzi, C., & Fornai, M. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.10.011 · Cited by 77
Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled Trial
Tan, A. H., Lim, S., Mahadeva, S., Loke, M. F., Tan, J. Y., Ang, B. H., Chin, K. P., Mohammad Adnan, A. F., Ong, S. M. C., Ibrahim, A. I., et al. (2020) · Movement Disorders · doi:10.1002/mds.28248 · Cited by 76
Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition
Lakhani, R., Vogel, K. R., Till, A., Liu, J., Burnett, S. F., Gibson, K. M., & Subramani, S. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303356 · Cited by 75 · cited 1×
“Besides the brain tissue, GABA is present in peripheral tissues such as the heart, stomach, small intestine, liver, and kidney (Akinci and Scho fi eld, 1999; Lakhani et al., 2014).”
BackgroundDong, X.-L., Wang, X., Liu, F., Liu, X., Du, Z.-R., Li, R. W., Xue, C.-H., Wong, K.-H., Wong, W.-T., Zhao, Q., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.180 · Cited by 75 · cited 1×
“Animal experiments have also reported that polymannuronic acid regulates GABA levels through the microbiota-gut-brain axis in PD mice to prevent the loss of dopaminergic neurons (Dong et al., 2020).”
BackgroundPerez-Pardo, P., de Jong, E. M., Broersen, L. M., van Wijk, N., Attali, A., Garssen, J., & Kraneveld, A. D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00057 · Cited by 74
He, Q., Yu, W., Wu, J., Chen, C., Lou, Z., Zhang, Q., Zhao, J., Wang, J., & Xiao, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078418 · Cited by 72
Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72
Bacterially produced metabolites protect C. elegans neurons from degeneration
Urrutia, A., García-Angulo, V. A., Fuentes, A., Caneo, M., Legüe, M., Urquiza, S., Delgado, S. E., Ugalde, J., Burdisso, P., & Calixto, A. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000638 · Cited by 71
Alipour Nosrani, E., Tamtaji, O. R., Alibolandi, Z., Sarkar, P., Ghazanfari, M., Azami Tameh, A., Taghizadeh, M., Banikazemi, Z., Hadavi, R., & Naderi Taheri, M. (2021) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1833917 · Cited by 69
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
Sun, P., Su, L., Zhu, H., Li, X., Guo, Y., Du, X., Zhang, L., & Qin, C. (2021) · Microorganisms · doi:10.3390/microorganisms9112281 · Cited by 69
Animal behavioral assessments in current research of Parkinson’s disease
Asakawa, T., Fang, H., Sugiyama, K., Nozaki, T., Hong, Z., Yang, Y., Hua, F., Ding, G., Chao, D., Fenoy, A. J., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.016 · Cited by 69
Self-citationThe Brain Metabolome of Male Rats across the Lifespan
Zheng, X., Chen, T., Zhao, A., Wang, X., Xie, G., Huang, F., Liu, J., Zhao, Q., Wang, S., Wang, C., et al. (2016) · Scientific Reports · doi:10.1038/srep24125 · Cited by 67
Bao, H., Li, H., Jia, Y., Xiao, Y., Luo, S., Zhang, D., Han, L., Dai, L., Xiao, C., Feng, L., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114561 · Cited by 67
Chronic glucocorticoid exposure activates BK-NLRP1 signal involving in hippocampal neuron damage
Zhang, B., Zhang, Y., Wu, W., Xu, T., Yin, Y., Zhang, J., Huang, D., & Li, W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0911-9 · Cited by 66
Self-citationNovel targets in Alzheimer’s disease: A special focus on microglia
Balducci, C., & Forloni, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.017 · Cited by 66
Li, Z., Lu, G., Li, Z., Wu, B., Luo, E., Qiu, X., Guo, J., Xia, Z., Zheng, C., Su, Q., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632482 · Cited by 66
Chen, S., Tan, B., Xia, Y., Liao, S., Wang, M., Yin, J., Wang, J., Xiao, H., Qi, M., Bin, P., et al. (2018) · Food & Function · doi:10.1039/c8fo02161a · Cited by 65
Yu, F., Han, W., Zhan, G., Li, S., Xiang, S., Zhu, B., Jiang, X., Yang, L., Luo, A., Hua, F., et al. (2019) · Aging · doi:10.18632/aging.101978 · Cited by 65
Zhao, L., Wang, Y., Zhang, G., Zhang, T., Lou, J., & Liu, J. (2019) · Nutrients · doi:10.3390/nu11123054 · Cited by 65
Serotonin, β‐amyloid, and cognition in Parkinson disease
Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R., & Albin, R. L. (2018) · Annals of Neurology · doi:10.1002/ana.25236 · Cited by 64
Jena, P. K., Sheng, L., Nguyen, M. V. L., Lucente, J. D., Hu, Y. C., Li, Y., Maezawa, I., Jin, L., & Wan, Y. Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00239-8 · Cited by 60
Terán-Ventura, E., Aguilera, M., Vergara, P., & Martínez, V. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.02.001 · Cited by 59
Karunaratne, T. B., Okereke, C., Seamon, M., Purohit, S. B., Wakade, C. G., & Sharma, A. (2020) · Nutrients · doi:10.3390/nu13010028 · Cited by 59
The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
Ghezzi, L., Cantoni, C., Rotondo, E., & Galimberti, D. (2022) · Biomedicines · doi:10.3390/biomedicines10071486 · Cited by 57
Helicobacter pylori eradication for Parkinson's disease
Rees, K., Stowe, R., Patel, S., Ives, N., Breen, K., Clarke, C. E., & Ben-Shlomo, Y. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008453.pub2 · Cited by 56
Joers, V., Masilamoni, G., Kempf, D., Weiss, A. R., Rotterman, T. M., Murray, B., Yalcin-Cakmakli, G., Voll, R. J., Goodman, M. M., Howell, L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105027 · Cited by 56
Meksawan, K., Chaotrakul, C., Leeaphorn, N., Gonlchanvit, S., Eiam-Ong, S., & Kanjanabuch, T. (2016) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2014.00015 · Cited by 54
Connecting the Gut Microbiota and Neurodegenerative Diseases: the Role of Bile Acids
Wang, S., Xu, C., Liu, H., Wei, W., Zhou, X., Qian, H., Zhou, L., Zhang, H., Wu, L. M., Chen, Z., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03340-9 · Cited by 54
Peralta Ramos, J. M., Iribarren, P., Bousset, L., Melki, R., Baekelandt, V., & Van der Perren, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00080 · Cited by 53
Sharma, S., Awasthi, A., & Singh, S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134516 · Cited by 53
Yan, Y., Ren, S., Duan, Y., Lu, C., Niu, Y., Wang, Z., Inglis, B., Ji, W., Zheng, Y., & Si, W. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00242-3 · Cited by 51
Rani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 50
Soares, R., Ribeiro, F. F., Xapelli, S., Genebra, T., Ribeiro, M. F., Sebastião, A. M., Rodrigues, C. M. P., & Solá, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0592-5 · Cited by 49
Song, C., Zhang, Y., Cheng, L., Shi, M., Li, X., Zhang, L., & Zhao, H. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111476 · Cited by 49
Self-citationSeifried, C., Boehncke, S., Heinzmann, J., Baudrexel, S., Weise, L. M., Gasser, T., Eggert, K. M., Fogel, W., Baas, H. K. J., Badenhoop, K. W. J., et al. (2012) · Neuroendocrinology · doi:10.1159/000343808 · Cited by 48
Jang, H., Kim, S., Lee, J. M., Oh, Y., Park, S. M., & Kim, S. R. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000740 · Cited by 48
Xie, M., Chen, H.-H., Nie, S.-P., Yin, J., & Xie, M.-Y. (2017) · Molecules · doi:10.3390/molecules22040653 · Cited by 45
Wong, Y. Y., Wu, C., Yu, D., Kim, E., Wong, M., Elez, R., Zebarth, J., Ouk, M., Tan, J., Liao, J., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.06.004 · Cited by 43
The Pharmacology of Autonomic Failure: From Hypotension to Hypertension
Biaggioni, I. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012161 · Cited by 41
Wu, L. M., Han, Y., Zheng, Z., Zhu, S., Chen, J., Yao, Y., Yue, S., Teufel, A., Weng, H., Li, L., et al. (2021) · Nutrients · doi:10.3390/nu13030940 · Cited by 41
Yuan, Q., Xin, L., Han, S. H., Su, Y., Wu, R., Liu, X., Wuri, J., Li, R., & Yan, T. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.644448 · Cited by 40
Lelieveld, I. M., Müller, M. L. T. M., Bohnen, N. I., Koeppe, R. A., Chervin, R. D., Frey, K. A., & Albin, R. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040166 · Cited by 38
Grigoruţă, M., Martínez-Martínez, A., Dagda, R. Y., & Dagda, R. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01838-9 · Cited by 38
The Blood–Brain Barrier in Psychoneuroimmunology
Banks, W. A. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.001 · Cited by 37
Wang, Q., Davis, P. B., Qi, X., Chen, S. G., Gurney, M. E., Perry, G. L., Doraiswamy, P. M., & Xu, R. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00917-1 · Cited by 37
Patterns of Gram-Stained Fecal Flora as a Quick Diagnostic Marker in Patients with Severe SIRS
Shimizu, K., Ogura, H., Tomono, K., Tasaki, O., Asahara, T., Nomoto, K., Morotomi, M., Matsushima, A., Nakahori, Y., Yamano, S., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1486-9 · Cited by 36
de Menezes, R. C. A., & Fontes, M. A. P. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.062 · Cited by 35
Cannon, T., Sinha, A., Trudeau, L., Maurice, C. F., & Gruenheid, S. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1830694 · Cited by 34
Probiotics as potential therapeutic options for Alzheimer’s disease
Ji, H., & Shen, L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11607-1 · Cited by 34
Exosome-Mediated Activation of Neuronal Cells Triggered by γ-Aminobutyric Acid (GABA)
Inotsuka, R., Udono, M., Yamatsu, A., Kim, M., & Katakura, Y. (2021) · Nutrients · doi:10.3390/nu13082544 · Cited by 31
Ilie, O., Paduraru, E., Robea, M. A., Balmuș, I.-M., Jijie, R., Nicoară, M., Ciobica, A. S., Nita, I.-B., Dobrin, R., & Doroftei, B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9629102 · Cited by 31
Zheng, H., Zhang, C., Zhang, J., & Duan, L. (2023) · Protein & Cell · doi:10.1093/procel/pwad020 · Cited by 31
Ibrahimagić, O. Ć., Jakubovic, A., Smajlović, D., Dostović, Z., Kunić, S., & Iljazović, A. (2016) · Medical Archives · doi:10.5455/medarh.2016.70.445-448 · Cited by 30
Upper brainstem GABA levels in Parkinson’s disease
Song, Y., Gong, T., Saleh, M. G., Mikkelsen, M. E., Wang, G., & Edden, R. A. E. (2021) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-021-00910-7 · Cited by 29
Could gut microbiota influence severity of Parkinson disease?
Malkki, H. A. I. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.195 · Cited by 28
Margineanu, M. B., Sherwin, E., Golubeva, A. V., Peterson, V. L., Hoban, A. E., Fiumelli, H., Rea, K., Cryan, J. F., & Magistretti, P. J. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.006 · Cited by 28
Gastrointestinal Dysfunction and Neuropathologic Correlations in Parkinson Disease
Mrabet, S., Ali, N., Achouri-Rassas, A., Dabbèche, R., Najjar, T., Haouet, S., & Belal, S. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000606 · Cited by 27
Elmaki, E. E. A., Gong, T., Nkonika, D. M., & Wang, G. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0714-z · Cited by 25
Lacerda, J. E. C., Campos, R. R., de Araújo, G. C., Leyen, S. A., Lopes, O. U., & Guertzenstein, P. G. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000900019 · Cited by 24
Huang, Y., Li, M., Zhou, L., Xu, D., Qian, F., Zhang, J., & Zhou, X. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6308021 · Cited by 24
Hair glucocorticoid levels in Parkinson’s disease
van den Heuvel, L. L., du Plessis, S., Stalder, T., Acker, D., Kirschbaum, C., Carr, J., & Seedat, S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104704 · Cited by 23
Kiriyama, Y., & Nochi, H. (2023) · Genes · doi:10.3390/genes14040825 · Cited by 22
Vagus nerve stimulation: a potential new treatment for ischaemic stroke
van der Meij, A., & Wermer, M. J. H. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00667-x · Cited by 21
Qin, W., Shi, Y., Chen, W., Jia, X., & Asakawa, T. (2022) · BioScience Trends · doi:10.5582/bst.2022.01352 · Cited by 20
Self-citationJi, T., Huang, H., Liu, J., Peng, T., Zhou, X., Tan, Q., Yuan, J., Hua, H., Ding, S., & Liu, H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14952 · Cited by 17 · cited 1×
“Some authors believed that speci fi c gut microbiota might be considered as a potential marker and therapeutic target for PD because the changes of PD-related gut microbiota are closely related to the occurrence and development of PD (Ji et al., 2021).”
BackgroundSingle-dose L-dopa increases upper brainstem GABA in Parkinson's disease: A preliminary study
Song, Y., Gong, T., Xiang, Y., Mikkelsen, M. E., Wang, G., & Edden, R. A. E. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117309 · Cited by 16
Valproate-induced parkinsonism, glial cells and Alexander's disease
Sechi, G., Conti, M., Sau, G. F., & Cocco, G. A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.03.022 · Cited by 13
Non-CNS pathogenic origin of Parkinson’s disease
Choudhry, H., & Perlmuter, L. C. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8588-7 · Cited by 13
An In Vitro Verification of the Effects of Paeoniflorin on Lipopolysaccharide‐Exposed Microglia
Chen, Q., Liu, Y., Zhang, Y., Jiang, X., Zhang, Y., & Asakawa, T. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5801453 · Cited by 13
Self-citationBuilding on 50 years of levodopa therapy
Neurology, T. L. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00349-x · Cited by 12
In vitro effects of Pueraria extract on ethanol-exposed microglia and neurons
Jiang, B., Yang, W.-H., Chen, L., Wang, S., Chen, S., Bao, Y., Chen, Q., Wang, Q., & Asakawa, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110163 · Cited by 10
Self-citation
Cited by
Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment
Zhao, P., Chen, Y., Zhou, S., & Li, F. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107896 · Cited by 48
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver, P. J., Civitelli, L., & Hu, M. T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13138-5 · Cited by 42
“Recent analyses reveal that early constipation and gastrointestinal complaints are seen in 80% of PD patients [23, 24].”
Heidari, H., & Lawrence, D. A. (2024) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2024.2378406 · Cited by 29
Hu, X., Song, L.-Z.-X., Zhang, Z.-Z., Ruan, X., Li, H., Yu, Z., & Huang, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1358525 · Cited by 20
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Vilela, C., Araújo, B., Soares-Guedes, C., Caridade-Silva, R., Martins‐Macedo, J., Teixeira, C., Gomes, E. D., Prudêncio, C., Vieira, M., & Teixeira, F. G. (2024) · Cells · doi:10.3390/cells13090770 · Cited by 20
Metadata
- Authors
- Jia, X., Chen, Q., Zhang, Y., & Asakawa, T.
- Affiliations
- Hainan Medical University (CN)
- Guangzhou University of Chinese Medicine (CN)
- Guangzhou Medical University (CN)
- Shenzhen Third People’s Hospital (CN)
- Corresponding author
- Zhang, Yuanyuan
- Asakawa, Tetsuya
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2023-12-15
- Volume
- 13
- Pages
- 1296713-1296713
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC10762314
- OpenAlex
- W4389794069
- Cited by
- 22
- References
- 283
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 4
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Guangzhou Medical University
- Guangzhou Municipal Science and Technology Bureau
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- gut microbiota, Parkinson's disease, microbiota-gut-brain axis, dysbiosis, neural pathways, probiotics, prebiotics, fecal microbiota transplantation, germ-free mice, neuroprotection
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Humans, Parkinson Disease, Ecosystem, Mice, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.